Advertisement
Screener

INFUSYSTEM HOLDINGS, INC (INFU) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

InfuSystem Holdings, Inc Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • InfuSystem Holdings, Inc return tang equity for the quarter ending 2026-06-30 was 16.77%, a 50.98% increase year-over-year.
  • InfuSystem Holdings, Inc return tang equity for the quarter ending 2026-03-31 was 15.70%, a 132.47% increase year-over-year.
  • InfuSystem Holdings, Inc return tang equity for the quarter ending 2025-12-31 was 13.65%, a 185.95% increase year-over-year.
  • InfuSystem Holdings, Inc return tang equity for the quarter ending 2025-09-30 was 11.83%, a 275.55% increase year-over-year.
  • InfuSystem Holdings, Inc return tang equity for fiscal 2025 was 12.84%, a 183.71% increase from fiscal 2024.
  • InfuSystem Holdings, Inc return tang equity for fiscal 2024 was 4.53%, a 141.80% increase from fiscal 2023.
  • InfuSystem Holdings, Inc return tang equity for fiscal 2023 was 1.87%, a 4297.45% increase from fiscal 2022.
  • InfuSystem Holdings, Inc return tang equity for fiscal 2022 was 0.04%, a 98.72% decline from fiscal 2021.
Available history
2009-12-31 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-06-3016.77%$8.54M$50.95M
2026-03-3115.70%$7.91M$50.38M
2025-12-3113.65%$6.63M$48.54M
2025-09-3011.83%$5.52M$46.68M
2025-06-3011.10%$5.07M$45.67M
2025-03-316.75%$3.19M$47.23M
2024-12-314.77%$2.35M$49.12M
2024-09-303.15%$1.48M$47.1M
2024-06-300.82%$366,000.00$44.83M
2024-03-310.19%$84,000.00$43.37M
2023-12-312.03%$872,000.00$42.9M
2023-09-302.16%$907,000.00$42.07M
2023-06-301.64%$661,000.00$40.3M
2023-03-310.16%$62,000.00$38.36M
2022-12-310.05%$18,000.00$37.49M
2022-09-300.80%$298,000.00$37.29M
2022-06-30-1.68%-$593,000.00$35.28M
2022-03-311.15%$391,000.00$34.12M
2021-12-314.10%$1.42M$34.63M
2021-09-3035.66%$11.7M$32.82M
2021-06-3050.41%$15.09M$29.94M
2021-03-3154.75%$18.41M$33.63M
2020-12-3156.80%$17.33M$30.51M
2020-09-3041.14%$7.47M$18.15M
2020-06-3040.77%$5.66M$13.89M
2020-03-3122.05%$1.9M$8.63M
2019-12-3129.63%$1.36M$4.59M
2019-09-307.06%$281,000.00$3.98M
2019-06-30-54.66%-$1.37M$2.51M
2019-03-31-112.78%-$2.26M$2M
2018-12-3158.06%-$1.1M-$1.89M
2018-09-301093.84%-$18.81M-$1.72M
2018-06-30-251.42%-$18.42M$7.33M
2018-03-31-213.64%-$19.03M$8.91M
2017-12-31-363.73%-$20.71M$5.69M
2017-09-30-13.56%-$3.19M$23.49M
2017-06-30-12.80%-$3M$23.44M
2017-03-31-7.14%-$1.74M$24.37M
2016-12-31-0.87%-$222,000.00$25.43M
2016-09-306.90%$1.78M$25.72M
2016-06-3011.12%$2.86M$25.7M
2016-03-3113.17%$3.35M$25.41M
2015-12-3111.12%$2.79M$25.06M
2015-09-309.87%$2.3M$23.26M
2015-06-3010.36%$2.01M$19.42M
2015-03-3110.27%$2.26M$21.96M
2014-12-3115.13%$3.36M$22.19M
2014-09-3015.15%$3.19M$21.02M
2014-06-3014.84%$2.98M$20.1M
2014-03-3111.47%$2.2M$19.19M
2013-12-319.04%$1.67M$18.46M
2013-09-305.91%$1.03M$17.36M
2013-06-302.48%$410,000.00$16.55M
2013-03-31-3.22%-$523,000.00$16.26M
2012-12-31-9.45%-$1.49M$15.75M
2012-09-30-16.41%-$2.47M$15.08M
2012-06-30-133.99%-$19.13M$14.28M
2012-03-31-346.86%-$46.19M$13.32M
2011-12-31-325.90%-$45.44M$13.94M
2011-09-30-240.91%-$46.84M$19.44M
2011-06-30-83.74%-$30.04M$35.87M

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-12-3112.84%$6.63M$51.62M
2024-12-314.53%$2.35M$51.82M
2023-12-311.87%$872,000.00$46.59M
2022-12-310.04%$18,000.00$42.29M
2021-12-313.34%$1.42M$42.56M
2020-12-3144.73%$17.33M$38.75M
2019-12-316.09%$1.36M$22.33M
2018-12-31-5.36%-$1.1M$20.44M
2017-12-31-66.90%-$20.71M$30.95M
2016-12-31-0.44%-$222,000.00$50.69M
2015-12-315.53%$2.79M$50.32M
2014-12-317.23%$3.36M$46.45M
2013-12-313.91%$1.67M$42.72M
2012-12-31-3.72%-$1.49M$40.01M
2011-12-31-113.14%-$45.44M$40.17M
2010-12-31-8.80%-$1.85M$21.05M
2009-12-310.95%$774,000.00$81.47M

Similar stocks

Stock NameCountryMarket CapPE Ratio
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
PRO DEX INC (PDEX)United States$0.234B13.64
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Neuronetics, Inc. (STIM)United States$0.216B-3.25
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Profound Medical Corp. (PROF)$0.206B-7.37